133 related articles for article (PubMed ID: 15095269)
21. [Our experience in the surgical treatment of gastrointestinal stromal tumors].
Mosca F; Stracqualursi A; Persi A; Zappalà O; Portale TR; Latteri S
Chir Ital; 2001; 53(6):809-20. PubMed ID: 11824056
[TBL] [Abstract][Full Text] [Related]
22. Gastrointestinal stromal tumors (GISTs): analysis of 20 cases.
Bölükbasi H; Nazli O; Tansug T; Bozdag AD; Isgiider AS; Yaman I; Haciyanli M; Genc H
Hepatogastroenterology; 2006; 53(69):385-8. PubMed ID: 16795978
[TBL] [Abstract][Full Text] [Related]
23. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome.
Feakins RM
Histopathology; 2005 Mar; 46(3):270-9. PubMed ID: 15720412
[TBL] [Abstract][Full Text] [Related]
24. Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma.
Aalto Y; Nordling S; Kivioja AH; Karaharju E; Elomaa I; Knuutila S
Genes Chromosomes Cancer; 1999 Jun; 25(2):104-7. PubMed ID: 10337993
[TBL] [Abstract][Full Text] [Related]
25. [Roles of risk assessment and Ki-67 index in judging prognostic of gastrointestinal stromal tumors].
Liang YM; Li XH; Chen W
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(15):1041-5. PubMed ID: 18754437
[TBL] [Abstract][Full Text] [Related]
26. Prognostic factors after surgery of primary resectable gastrointestinal stromal tumours.
Aparicio T; Boige V; Sabourin JC; Crenn P; Ducreux M; Le Cesne A; Bonvalot S
Eur J Surg Oncol; 2004 Dec; 30(10):1098-103. PubMed ID: 15522557
[TBL] [Abstract][Full Text] [Related]
27. Chromosomal gains and losses detected by comparative genomic hybridization and proliferation activity in renal cell carcinoma.
Kallio JP; Mahlamäki EH; Helin H; Karhu R; Kellokumpu-Lehtinen P; Tammela TL
Scand J Urol Nephrol; 2004; 38(3):225-30. PubMed ID: 15204376
[TBL] [Abstract][Full Text] [Related]
28. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
[TBL] [Abstract][Full Text] [Related]
29. Complex genetic alterations in gastrointestinal stromal tumors with autonomic nerve differentiation.
Debiec-Rychter M; Pauwels P; Lasota J; Franke S; De Vos R; De Wever I; Hagemeijer A; Sciot R
Mod Pathol; 2002 Jul; 15(7):692-8. PubMed ID: 12118105
[TBL] [Abstract][Full Text] [Related]
30. Chromosomal gains at 9q characterize enteropathy-type T-cell lymphoma.
Zettl A; Ott G; Makulik A; Katzenberger T; Starostik P; Eichler T; Puppe B; Bentz M; Müller-Hermelink HK; Chott A
Am J Pathol; 2002 Nov; 161(5):1635-45. PubMed ID: 12414511
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression.
Noguchi T; Wirtz HC; Michaelis S; Gabbert HE; Mueller W
Am J Clin Pathol; 2001 Jun; 115(6):828-34. PubMed ID: 11392878
[TBL] [Abstract][Full Text] [Related]
32. Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology.
Morohara K; Nakao K; Tajima Y; Nishino N; Yamazaki K; Kaetsu T; Suzuki S; Tsunoda A; Kawamura M; Aida T; Tachikawa T; Kusano M
Cancer Genet Cytogenet; 2005 Aug; 161(1):57-62. PubMed ID: 16080958
[TBL] [Abstract][Full Text] [Related]
33. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy.
Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM
Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229
[TBL] [Abstract][Full Text] [Related]
34. Novel candidate tumour suppressor gene loci on chromosomes 11q23-24 and 22q13 involved in human insulinoma tumourigenesis.
Jonkers YM; Claessen SM; Feuth T; van Kessel AG; Ramaekers FC; Veltman JA; Speel EJ
J Pathol; 2006 Dec; 210(4):450-8. PubMed ID: 17068744
[TBL] [Abstract][Full Text] [Related]
35. Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.
Speel EJ; Scheidweiler AF; Zhao J; Matter C; Saremaslani P; Roth J; Heitz PU; Komminoth P
Cancer Res; 2001 Jul; 61(13):5186-92. PubMed ID: 11431358
[TBL] [Abstract][Full Text] [Related]
36. Preferential loss of 5q14-21 in intestinal-type gastric cancer with DNA aneuploidy.
Oga A; Kong G; Ishii Y; Izumi H; Park CY; Sasaki K
Cytometry; 2001 Feb; 46(1):57-62. PubMed ID: 11241508
[TBL] [Abstract][Full Text] [Related]
37. Genetic and pathologic characteristics of gastrointestinal stromal tumors in extragastric lesions.
Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
Int J Mol Med; 2006 Dec; 18(6):1067-71. PubMed ID: 17089009
[TBL] [Abstract][Full Text] [Related]
38. Genomic aberrations in carcinomas of the uterine corpus.
Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
[TBL] [Abstract][Full Text] [Related]
39. Proliferating cell nuclear antigen immunoreactivity and prognosis of gastrointestinal stromal tumors.
Franquemont DW; Frierson HF
Mod Pathol; 1995 Jun; 8(5):473-7. PubMed ID: 7675763
[TBL] [Abstract][Full Text] [Related]
40. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
